LogicBio Therapeutics Inc. (LOGC) Gained 12.58% or 2.04 To Price $18.25 On Tuesday


LogicBio Therapeutics Inc. (LOGC) gained 12.58% or 2.04 to $18.25. It is close to 10121 shares traded, which is 28.96% compare to the average total volume 34952. The market cap of LOGC is $410.52 million. The year to date change is 74.69%. The 52 week price range is from $6.7 to $20.07. Price of LOGC have changed 9.90% during last week. It have changed 27.54% over last month, 64.24% over last 3 months, 1.63% over last 6 months and 40.96% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for LOGC is 12.27. It is -32.77% below current price. The 200-day Moving Averages for LOGC is 11.14. It is -38.96% below current price. The 52-week High is 20.07. It is 9.97% from the current price. The 52-week Low is 6.7. It is -63.29% from current price.

There are some statistics of LOGC. It is has market cap $410.52 million. The share outstanding is 22.49 million. The average volume is 34952. The percent of top 15 Institution holding is 61.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of LOGC is -28.03%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of LOGC is -26.63%.


Tags:

Share this post